Guardant Health DSO Ratio 2011-2026 | GH

Annual DSO Ratio Guardant Health

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
46.1	49.2	60.2	79.1	73.7	64.5	81.7	144	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
144	46.1	74.8

Quarterly DSO Ratio Guardant Health

2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
48.3	50.6	-	45	47.6	46.9	-	55.9	57.8	65.4	-	33.5	35.2	86.4	-	55.1	50.4	58.8	-	65.2	73.3	68.5	-	72	81.1	104	-	150	168	132	-	52.4	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
168	33.5	71

DSO Ratio of other stocks in the Diagnostics research industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
BioNano Genomics BNGO	63.7	$ 1.14	0.88 %	$ 6.21 M	USA
Burning Rock Biotech Limited BNR	31.7	$ 16.07	1.39 %	$ 173 M	China
Centogene N.V. CNTG	145	-	-6.23 %	$ 30.6 M	Germany
Agilent Technologies A	63.8	$ 115.83	0.67 %	$ 35.2 B	USA
Interpace Biosciences IDXG	66.9	$ 2.13	-7.28 %	$ 9.42 M	USA
Aspira Women's Health AWH	1.17 K	-	-6.19 %	$ 10.5 M	USA
Biocept BIOC	112	-	-13.05 %	$ 7.29 M	USA
Chembio Diagnostics CEMI	66.3	-	0.22 %	$ 16.8 M	USA
DermTech DMTK	80.6	-	-11.32 %	$ 2.94 M	USA
CareDx, Inc CDNA	51.5	$ 16.4	2.15 %	$ 874 M	USA
Oxford Immunotec Global PLC OXFD	90.8	-	-	$ 562 M	Britain
Akumin AKU	57.4	-	-17.87 %	$ 25.9 M	Canada
Myriad Genetics MYGN	52.3	$ 4.51	3.79 %	$ 418 M	USA
NeoGenomics NEO	77.7	$ 7.92	2.99 %	$ 1.01 B	USA
Enzo Biochem ENZ	50.3	-	-8.98 %	$ 14.8 K	USA
Co-Diagnostics CODX	94.7	$ 1.39	1.09 %	$ 1.85 M	USA
Exact Sciences Corporation EXAS	30.8	-	-	$ 19.8 B	USA
Accelerate Diagnostics AXDX	291	-	-61.36 %	$ 2.46 M	USA
Castle Biosciences CSTL	49.2	$ 23.03	-0.44 %	$ 640 M	USA
Global Cord Blood Corporation CO	112	-	-	$ 399 M	China
Fluidigm Corporation FLDM	67.2	-	1.08 %	$ 308 M	USA
Genetic Technologies Limited GENE	11.7 K	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	122	-	0.12 %	$ 80.1 M	China
Charles River Laboratories International CRL	65	$ 178.3	1.51 %	$ 8.84 B	USA
PRA Health Sciences, Inc. PRAH	98.1	-	-	$ 10.7 B	USA
Senseonics Holdings SENS	10.3	$ 6.67	-0.15 %	$ 278 M	USA
Medpace Holdings MEDP	50.4	$ 498.16	0.94 %	$ 14.4 B	USA
Soleno Therapeutics SLNO	27	$ 52.65	0.04 %	$ 2.68 B	USA
Danaher Corporation DHR	55.3	$ 192.41	1.48 %	$ 137 B	USA
Neuronetics STIM	48.7	$ 1.35	-0.37 %	$ 89 M	USA
Heska Corporation HSKA	40.8	-	-	$ 1.31 B	USA
HTG Molecular Diagnostics HTGM	101	-	-20.0 %	$ 1.06 M	USA
Illumina ILMN	61.3	$ 123.83	2.4 %	$ 19.7 B	USA
Fulgent Genetics FLGT	77.4	$ 15.15	5.0 %	$ 458 M	USA
Thermo Fisher Scientific TMO	70	$ 504.05	1.6 %	$ 190 B	USA
Trinity Biotech plc TRIB	87.2	$ 0.69	-3.37 %	$ 61.9 M	Irlanda
QIAGEN N.V. QGEN	30.8	-	-	$ 10.6 B	Niderland
Anixa Biosciences ANIX	275	$ 2.76	2.6 %	$ 89.6 K	USA
Biomerica BMRA	57.7	$ 2.07	-3.05 %	$ 4.75 M	USA
Twist Bioscience Corporation TWST	44.5	$ 48.96	2.19 %	$ 2.93 B	USA
Invitae Corporation NVTA	242	-	-	$ 21.2 M	USA
ICON Public Limited Company ICLR	68.5	$ 108.9	1.95 %	$ 8.98 B	Irlanda
Laboratory Corporation of America Holdings LH	52.9	$ 262.21	0.49 %	$ 21.8 B	USA
Natera NTRA	81.5	$ 198.02	2.58 %	$ 19.5 B	USA
Lantheus Holdings LNTH	80.5	$ 80.89	0.37 %	$ 5.46 B	USA
Motus GI Holdings MOTS	77.2	-	-34.28 %	$ 263 K	Israel